Ann Hynes
Stock Analyst at Mizuho
(4.20)
# 476
Out of 5,182 analysts
290
Total ratings
61.29%
Success rate
10.27%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Outperform | $50 → $52 | $47.49 | +9.50% | 5 | Mar 18, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $235 → $265 | $177.50 | +49.30% | 17 | Mar 12, 2026 | |
| MOH Molina Healthcare | Maintains: Outperform | $220 → $180 | $185.46 | -2.94% | 10 | Mar 12, 2026 | |
| ELV Elevance Health | Maintains: Outperform | $413 → $350 | $362.74 | -3.51% | 7 | Mar 11, 2026 | |
| CNC Centene | Maintains: Neutral | $47 → $41 | $49.57 | -17.29% | 10 | Mar 11, 2026 | |
| SGRY Surgery Partners | Maintains: Outperform | $19 → $17 | $14.35 | +18.47% | 5 | Mar 5, 2026 | |
| HCA HCA Healthcare | Maintains: Outperform | $540 → $585 | $431.92 | +35.44% | 24 | Feb 25, 2026 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $215 → $175 | $166.79 | +4.92% | 5 | Feb 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Outperform | $210 → $235 | $195.05 | +20.48% | 17 | Feb 12, 2026 | |
| UNH UnitedHealth Group | Maintains: Outperform | $430 → $350 | $366.77 | -4.57% | 22 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $13 | $10.76 | +20.82% | 6 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $20 → $12 | $9.71 | +23.58% | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $17 | $27.58 | -38.36% | 13 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $80.98 | +17.31% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $575 → $655 | $409.65 | +59.89% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $285 → $320 | $259.57 | +23.28% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $345 | $229.72 | +50.18% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $190 → $225 | $158.98 | +41.53% | 13 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $173 → $225 | $102.49 | +119.53% | 16 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $22.96 | -34.67% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $205.61 | -41.64% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $22.56 | +24.11% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $101.69 | -6.58% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $284.92 | +35.13% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $162.54 | +23.05% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.11 | +24,044.14% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $835.00 | -39.52% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $0.87 | +6,476.67% | 1 | Sep 21, 2017 |
BrightSpring Health Services
Mar 18, 2026
Maintains: Outperform
Price Target: $50 → $52
Current: $47.49
Upside: +9.50%
Tenet Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $235 → $265
Current: $177.50
Upside: +49.30%
Molina Healthcare
Mar 12, 2026
Maintains: Outperform
Price Target: $220 → $180
Current: $185.46
Upside: -2.94%
Elevance Health
Mar 11, 2026
Maintains: Outperform
Price Target: $413 → $350
Current: $362.74
Upside: -3.51%
Centene
Mar 11, 2026
Maintains: Neutral
Price Target: $47 → $41
Current: $49.57
Upside: -17.29%
Surgery Partners
Mar 5, 2026
Maintains: Outperform
Price Target: $19 → $17
Current: $14.35
Upside: +18.47%
HCA Healthcare
Feb 25, 2026
Maintains: Outperform
Price Target: $540 → $585
Current: $431.92
Upside: +35.44%
Charles River Laboratories International
Feb 20, 2026
Maintains: Neutral
Price Target: $215 → $175
Current: $166.79
Upside: +4.92%
Quest Diagnostics
Feb 12, 2026
Maintains: Outperform
Price Target: $210 → $235
Current: $195.05
Upside: +20.48%
UnitedHealth Group
Feb 5, 2026
Maintains: Outperform
Price Target: $430 → $350
Current: $366.77
Upside: -4.57%
Dec 18, 2025
Maintains: Neutral
Price Target: $11 → $13
Current: $10.76
Upside: +20.82%
Dec 18, 2025
Maintains: Outperform
Price Target: $20 → $12
Current: $9.71
Upside: +23.58%
Dec 18, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $27.58
Upside: -38.36%
Dec 10, 2025
Maintains: Outperform
Price Target: $88 → $95
Current: $80.98
Upside: +17.31%
Oct 24, 2025
Maintains: Outperform
Price Target: $575 → $655
Current: $409.65
Upside: +59.89%
Oct 17, 2025
Maintains: Outperform
Price Target: $285 → $320
Current: $259.57
Upside: +23.28%
Oct 9, 2025
Maintains: Outperform
Price Target: $300 → $345
Current: $229.72
Upside: +50.18%
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $158.98
Upside: +41.53%
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $102.49
Upside: +119.53%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $22.96
Upside: -34.67%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $205.61
Upside: -41.64%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $22.56
Upside: +24.11%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $101.69
Upside: -6.58%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $284.92
Upside: +35.13%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $162.54
Upside: +23.05%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.11
Upside: +24,044.14%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $835.00
Upside: -39.52%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $0.87
Upside: +6,476.67%